-
Autism in schizophrenia and its original link to self-disorder: returning a borrowed concept Lancet Psychiatry (IF 30.8) Pub Date : 2025-06-03
Mads Gram Henriksen, Kasper Møller Nielsen, Laurent Mottron, Julie NordgaardAutism was introduced by Eugen Bleuler in 1910 as a defining feature of schizophrenia, and it remained so for 80 years. However, the concept was borrowed by Leo Kanner and Hans Asperger to describe another condition (infantile autism) and eventually awareness of autistic features in schizophrenia declined. Today, autistic features are by default considered indicative of autism spectrum disorder, and
-
Values and preferences regarding the health sector response to interpersonal violence against transgender and gender-diverse individuals: a systematic review Lancet Psychiatry (IF 30.8) Pub Date : 2025-06-02
Rose Pollard Kaptchuk, Katrina S Kennedy, Brooke Wong, Ping Teresa Yeh, Erin E Cooney, Caitlin KennedyTransgender and gender-diverse (TGD) people are disproportionately affected by interpersonal violence and face barriers to accessing post-violence health services globally. Post-violence care guidelines are broadly applicable, but specific considerations for TGD individuals have not been synthesised. In this systematic review, we synthesise the values and preferences of TGD adults and health providers
-
Recognition in Winnicott’s “The Use of an Object and Relating Through Identifications” J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-31
Giuseppe CivitareseA seminal text in psychoanalytic literature, “The Use of an Object and Relating Through Identifications,” like the Sphinx, continues to challenge us. At birth, the infant attempts to destroy the object, and if the mother survives this destruction, the child gains a sense of reality. In this essay, Winnicott challenges classical conceptions of aggression, viewing destruction as an expression of love
-
Correction to Lancet Psychiatry 2025; 12: 355–65 Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-29
Farhat LC, Lannes A, Del Giovane C, et al. Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2025; 12: 355–65—In this Article, the spelling of the name Anneka Tomlinson was incorrect. This correction has been made to the online version as of May 29, 2025
-
Political abuse in psychiatry: avoid repeating history Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-28
CheyAnne Olivia RiveraNo Abstract
-
Physician Suicide and Associated Features-What Defines a Physician? JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-28
Flora Lum -
Dry EEG-From Laboratory to Living Room. JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-28
Mohammad S E Sendi -
Physician Suicide and Associated Features-What Defines a Physician?-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-28
Hirsh Makhija,Judy E Davidson,Sidney Zisook -
Childhood Maternal Warmth, Social Safety Schemas, and Adolescent Mental and Physical Health JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-28
Jenna Alley, Dimitris I. Tsomokos, Summer Mengelkoch, George M. SlavichImportanceAlthough early maternal warmth strongly predicts adolescent health, questions remain about the biopsychosocial mechanisms underlying this association.ObjectiveTo understand how maternal warmth at 3 years of age shapes adolescent social safety schemas at 14 years of age and physical and mental health at 17 years of age.Design, Setting, and ParticipantsThe Millennium Cohort Study tracks approximately
-
Prevalence of Suicidal Ideation and Suicide Attempts by Race and Gender in Three Large U.S. Adolescent Cohorts. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Ashley M Cooper,Elina Visoki,Kate T Tran,Ezer Elbaz,Mārtiņš M Gataviņš,Sarah McKetta,Joel A Fein,Tami D Benton,Ran Barzilay -
Self-Control Abilities in Specific Types of Problematic Usage of the Internet: Findings From Clinically Validated Samples With Neurocognitive Tasks. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Silke M Müller,Stephanie Antons,Anna M Schmid,Tobias A Thomas,Annica Kessling,Maithilee Joshi,Kseniya Krikova,Miriam Kampa,Lukas Mallon,Lasse David Schmidt,Lena Klein,Nanne Dominick,Kjell Büsche,Andreas Oelker,Annika Brandtner,Christian Montag,Klaus Wölfling,Oliver T Wolf,Martin Diers,Tim Klucken,Hans-Jürgen Rumpf,Rudolf Stark,Astrid Müller,Elisa Wegmann,Sabine Steins-Loeber,Matthias BrandOBJECTIVE Reduced cognitive functions are commonly associated with diminished self-control abilities. Research on cognitive functions in gaming disorder and other specific types of problematic usage of the Internet (PUI) remains rare. The aim of this study was to compare performance in different cognitive domains between clinically validated groups of individuals with and without specific PUI. METHODS
-
Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Lusi Zhang,Elena I Ivleva,David A Parker,Scot K Hill,Paulo L Lizano,Richard S E Keefe,Sarah K Keedy,Jennifer E McDowell,Godfrey D Pearlson,Brett A Clementz,Matcheri S Keshavan,Elliot S Gershon,Carol A Tamminga,John A Sweeney,Jeffrey R BishopOBJECTIVE The authors sought to determine whether genetic predispositions to cognitive ability or psychiatric conditions interact with anticholinergic burden (AChB) to impact cognition and brain structure in individuals with psychotic disorders. METHODS Participants with psychosis spectrum disorders (N=1,704) from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) consortium, 18-65
-
National Trends in Suicidal Thoughts and Suicide Attempts Among High School Students in the United States. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Tanner J Bommersbach,Mark Olfson,Taeho Greg RheeOBJECTIVE The authors sought to estimate national trends in suicidal thoughts and attempts among high school students with and without health-risk behaviors. METHODS Data were analyzed from the 2007 to 2021 Youth Risk Behavior Survey, a biennial cross-sectional survey of U.S. high school students (unweighted sample, N=119,654). Suicidal thoughts were defined as seriously considering attempting suicide
-
Introduction to HelÍ Rafael Morales Ascencio’s Psychoanalytic Work J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-28
Mina Levinsky-Wohl, Gabriela Legorreta -
Suicide decriminalisation in the United Arab Emirates Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-23
Sumaya Al Marzooqi, Mark Mohan Kaggwa, Adel El Sheikh, Amani Ahmed Ibrahim, Gary Andrew Chaimowitz, Andrew Toyin OlagunjuNo Abstract
-
Correction to Lancet Psychiatry 2025; 12: 410–20 Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-22
Horsdal HT, Albiñana C, Zhu Z, et al. Convergent evidence linking neonatal vitamin D status and risk of neurodevelopmental disorders: a Danish case-cohort study. Lancet Psychiatry 2025; 12: 410–20—In this Article, Prof P B Mortensen's degree should read DrMedSc; the second sentence of the Findings subsection in the Summary and the second sentence of the Results section, should end “...we measured 25(OH)D
-
Evaluation of a Smartphone App Intervention with Telephone Guidance as Transitional Support from Inpatient Treatment to Continuing Care for Individuals with Alcohol Use Disorder: Results from a Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-05-23
Sebastian Saur,Kiona K Weisel,Catharina Lang,Lukas M Fuhrmann,Niklas Meurer,Daniela Reichl,Mathias Zink,Peter Heepe,Thomas Hillemacher,Wolf-Dietrich Braunwarth,Peter Falkai,Gabriele Koller,Yaroslav Kiderman,Thomas Kraus,Johannes Kornhuber,Philipp Spitzer,Dominikus Bönsch,Mark Stemmler,Anja Hildebrand,Sabine Steins-Loeber,Matthias BerkingINTRODUCTION Relapse rates in individuals with alcohol use disorder (AUD) are particularly high following inpatient treatment. Innovative strategies should specifically target the transitional gap between completion of inpatient treatment and uptake of standard continuing care. This study aimed to determine whether Appstinence, a digital approach that combines a smartphone app intervention with adjunct
-
Efficacy of team‑based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease: Results from the multicenter, randomized controlled TEACH trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-05-23
Monika Sadlonova,Birgit Herbeck Belnap,Ingrid Becker,Kristina Bersch,Franziska Geiser,Viktoria Adenauer,Martin Hellmich,Ingrid Kindermann,Angela Zimmer,Matthias Michal,Jasmin Ghaemi Kerahrodi,Mariel Nöhre,Martina de Zwaan,Astrid Petersmann,Irina Müller-Kozarez,Maja Ehlers,Rolf Wachter,Christian Albus,Christoph Herrmann-Lingen,INTRODUCTION Coronary heart disease (CHD) has serious implications for patients´ quality of life (QoL). Psychological distress affects 15 to 40% of patients with CHD and is robustly associated with poorer prognosis. Blended collaborative care (BCC), a telephone-delivered intervention involving non-physician care managers that address both psychological and medical factors can be applied for secondary
-
Correction to Lancet Psychiatry 2024; 11: 620–32 Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-21
Gao Y, Staginnus M, and the ENIGMA-Antisocial Behavior Working Group. Cortical structure and subcortical volumes in conduct disorder: a coordinated analysis of 15 international cohorts from the ENIGMA-Antisocial Behavior Working Group. Lancet Psychiatry 2024; 11: 620–32—The appendix of this Article has been corrected as of May 21, 2025.
-
Book Review: Emerging Adulthood: A Psychodynamic Approach to the New Developmental Phase of the 21st Century Book Review: Emerging Adulthood: A Psychodynamic Approach to the New Developmental Phase of the 21st Century. By Karen Gilmore and Pamela Meersand . Washington, DC: American Psychiatric Publishing, 2024, 324 pp., $74 paperback. J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-22
Timothy Rice -
Private Equity Among US Psychiatric Hospitals JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-21
Morgan C. Shields, Yuanyuan Yang, Susan H. BuschImportancePrivate equity (PE) ownership in health care has increased, but evidence for its association with health care quality is mixed. Moreover, there is no evidence regarding inpatient psychiatric hospitals, despite considerable patient vulnerabilities.ObjectiveTo describe trends in PE ownership of psychiatric hospitals from 2013 through 2021 and the cross-sectional association between PE ownership
-
Loss of PTSD Diagnosis in Response to Evidence-Based Treatments JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-21
Tiffany Milligan, Derek Smolenski, Jose Lara-Ruiz, Marija S. KelberImportanceIn recent decades, evidence-based psychotherapies to treat posttraumatic stress disorder (PTSD) have been developed with robust evidence bases. However, efficacy observed in clinical trials is not always directly applicable to clinical practice.ObjectiveTo estimate the percentage of patients in both military and veteran (hereafter milvet) and nonmilvet populations that lose their PTSD diagnosis
-
Local Anesthetics Adulterating the Illicit Fentanyl Supply JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-21
Joseph J. Palamar, Joshua S. DeBord, Alex J. Krotulski, Bruce A. GoldbergerThis Viewpoint examines the use of local anesthetics to adulterate synthetic opioids, particularly illicitly manufactured fentanyl, and the dangers associated with exposure to these drugs.
-
Why I Write: The Warp and Weft J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-16
Lisa Gornick -
The big-data balancing act Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
The Lancet PsychiatryNo Abstract
-
Vitamin D status in newborns and long-term neuropsychiatric outcomes Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
Isabel Gamache, Wiame Belbellaj, Basile Jumentier, Despoina ManousakiNo Abstract
-
Advancing clinical trials for anxiety disorders in older adults Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
Carly J JohncoNo Abstract
-
Adolescent mental health measures Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
Laura Duncan, R Christopher SheldrickNo Abstract
-
Awais Aftab: a multidimensional approach to psychiatry Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
Talha BurkiNo Abstract
-
Convergent evidence linking neonatal vitamin D status and risk of neurodevelopmental disorders: a Danish case-cohort study Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
Henriette Thisted Horsdal PhD, Clara Albiñana PhD, Zhihong Zhu PhD, Sanne Grundvad Boelt PhD, Nis Borbye-Lorenzen PhD, Arieh S Cohen PhD, Kristin Skogstrand PhD, Lars Melgaard MSc, Nadia Jensen MacSween, Marta Jadwiga Thorbek MSc, Oleguer Plana-Ripoll PhD, Liselotte Vogdrup Petersen PhD, Prof Cynthia M Bulik PhD, Prof Anders D Børglum MD, Prof Ole Mors MD, Prof Merete Nordentoft DMSc, Prof Thomas WergeThere is growing evidence linking neonatal vitamin D deficiency to an increased risk of schizophrenia, ADHD, and autism spectrum disorder (ASD). The aim of this study was to examine the association between two vitamin D biomarkers (25 hydroxyvitamin D [25(OH)D] and vitamin D-binding protein [DBP], and their related genetic correlates) and the risk of six mental disorders.
-
Pharmacological treatment of anxiety in older adults: a systematic review and meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
Sarah E Neil-Sztramko PhD, AnneMarie Levy PhD, Prof Alastair J Flint, Zahra Goodarzi MD, Amy Gough MD, Shanna C Trenaman PhD, Prof Michael Van Ameringen MD, Erica Weir MD, Anthony Yeung MD, Mahnoor R Akram MScPT, Titus A Chan MSW, Sébastien Grenier PhD, Heli Juola MSW, Juliette Mojgani HBSc, Kristin Reynolds PhD, Carly Whitmore PhD, Andrea Iaboni MDAnxiety and its disorders are common in later life. Given the known risks of psychopharmacological treatments in older adults, clinical decision making for anxiety management should be guided by the strongest available evidence. This study aimed to comprehensively synthesise evidence on the pharmacological treatment of anxiety in older adults.
-
Mindfulness-based cognitive therapy versus treatment as usual after non-remission with NHS Talking Therapies high-intensity psychological therapy for depression: a UK-based clinical effectiveness and cost-effectiveness randomised, controlled, superiority trial Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-14
Prof Thorsten Barnhofer PhD, Prof Barnaby D Dunn PhD, Prof Clara Strauss PhD, Florian A Ruths MD, Prof Barbara Barrett PhD, Mary Ryan MD, Asha Ladwa PhD, Frances Stafford MSc, Roberta Fichera MSc, Hannah Baber BSc, Ailis McGuinness BSc, Isabella Metcalfe MSc, Daniel K Y Kan BSc, Joanna Pooley MSc, Delilah Harding MSc, Emma Tassie PhD, James Carson MSc, Shelley Rhodes PhD, Prof Allan H Young MD, JamesNon-remission after psychological therapy for major depressive disorder is common, yet there are no established further-line treatments. In the UK National Health Service (NHS) Talking Therapies programme, about 50% of patients with depression who come to the end of the stepped care pathway do not show remission of symptoms. We aimed to investigate whether mindfulness-based cognitive therapy (MBCT)
-
Purposeful Drug Repurposing JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-14
Peter Nagele, Charles R. Conway, Charles F. ZorumskiThis Viewpoint discusses a proposal to identify candidates for drug repurposing and allocate US Food and Drug Administration funds to cover the cost of evaluating and approving such drugs for their novel indications.
-
Health Outcomes of Discontinuing Antipsychotics After Hospitalization in Older Adults JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-14
Chun-Ting Yang, James M. Wilkins, Elyse DiCesare, Kevin T. Pritchard, Qiaoxi Chen, Yichi Zhang, Dae Hyun Kim, Kueiyu Joshua LinImportanceAmong hospitalized older adults, prolonged use of antipsychotic medications (APMs) following hospital discharge may increase the risk of APM-associated adverse events. There are limited data on whether early discontinuation of APMs is associated with reduced adverse clinical outcomes compared with APM continuation after discharge.ObjectiveTo compare clinical outcomes between discontinuation
-
Glucagon-Like Peptide 1 Receptor Agonists and Mental Health JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-14
Aureliane C. S. Pierret, Yuya Mizuno, Pippa Saunders, Eshaya Lim, Riccardo De Giorgi, Oliver D. Howes, Robert A. McCutcheon, Barbara McGowan, Piya Sen Gupta, Daniel Smith, Khalida Ismail, Toby PillingerImportancePeople with obesity and diabetes have poorer psychiatric and cognitive outcomes and lower quality of life (QOL) compared with those without. Glucagon-like peptide 1 receptor agonists (GLP1-RAs) are treatments for diabetes and obesity that may also influence psychiatric outcomes.ObjectiveTo conduct a meta-analysis of randomized placebo-controlled trials to evaluate psychiatric, cognitive,
-
Psychiatric Prognosis Following Index Suicide Attempts in Early Adolescents JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-14
Tanner J. Bommersbach, Grace Johnson, Vanessa K. Pazdernik, J. Michael Bostwick, Alastair J. S. McKeanImportanceThe rates of suicide and suicide attempts are rising precipitously among early adolescents aged 10 to 14 years in the US. While suicide attempts in this age group are more common and associated with lower lethality than in older age groups, very little is known about these individuals’ long-term social and psychiatric outcomes.ObjectivesTo examine the adult outcomes of individuals making
-
Foreign Book Review Book Review: Il disagio psichico, la psicoanalisi, i ruoli pubblici: Testimonianze [Mental Distress, Psychoanalysis, Public Roles: Testimonies]. Edited by BettiLoredanaGalianiRiccardoRuggieroVincenzo. Rome, Italy: Alpes Italia, 2024, 142 pp. J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-12
Ronny Jaffé, Sarantis Thanopulos, Michele S. Piccolo -
Book Review: Life After Death: Surviving Suicide Life After Death: Surviving Suicide. By BrockmanRichard. New York: Arcade Publishing, 2023, 389 pp., $26.99 hardcover. J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-10
Judith L. Lewis, Grace E. Andrews -
Correction to Lancet Psychiatry 2025; 12: 266–75 Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-08
Nomura N, Siafis S, Schneider-Thoma J, et al. The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials inacute phase schizophrenia. Lancet Psychiatry 2025; 12: 266–75—The appendix of this Article has been corrected as of May 8, 2025.
-
Genetic Architecture and Risk of Childhood Maltreatment Across 5 Psychiatric Diagnoses. JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-09
Trine Tollerup Nielsen,Paraskevi Bali,Jakob Grove,Christina Mohr-Jensen,Thomas Werge,Søren Dalsgaard,Anders D Børglum,Edmund Sonuga-Barke,Helen Minnis,Ditte Demontis,,Elizabeth C Corfield,Ludger Tbartz van Elst,Manuel Mattheisen,Melanie M de Wit,Mohammed Jashim Uddin,Richard J L Anney,Stephen W Scherer,Thomas Bourgeron,Tinca J C PoldermanImportance Childhood maltreatment (CM) is associated with psychiatric disorders. The underlying mechanisms are complex and involve genetics. Objective To investigate the polygenic architecture of CM-exposed individuals across psychiatric conditions and if genetics modulates absolute CM risk in the presence of high-impact risk factors such as parental psychiatric diagnoses. Design, Setting, and Participants
-
In psychedelic-assisted therapy, the alliance in the psychotherapy component is as important as the drug. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-05-09
Christoph Flückiger,Madita Böhme,Ann-Marie Schweizer,Juan-Martín Gómez Penedo,Bruce E Wampold -
Reproductive rights of women with severe mental disability and rights of their children in China Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-08
Yang Zhang, Xingbo Suo, Jin GaoNo Abstract
-
Short-term versus long-term mentalization-based therapy for borderline personality disorder (MBT-RCT): 24 months follow-up of a randomized clinical trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-05-08
Sophie Juul,Janus Christian Jakobsen,Emilie Hestbaek,Caroline Barkholt Kamp,Markus Harboe Olsen,Marie Rishede,Frederik Weischer Frandsen,Sune Bo,Stig Poulsen,Per Sørensen,Anthony Bateman,Sebastian SimonsenIntroduction Borderline personality disorder (BPD) is a severe and prevalent psychiatric disorder. Mentalization-based therapy (MBT) is an evidence-based intervention for BPD, which is often delivered as a long-term psychotherapy program for BPD. We previously published a randomized clinical trial assessing short-term versus long-term MBT for BPD 16 months after randomization as the primary follow-up
-
Recovery-oriented psychiatry: oxymoron or catalyst for change? Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-06
Helene Speyer, David Roe, Mike SladeThis Personal View provides a normative and conceptual analysis of the intersection between the recovery movement and psychiatry. Although recovery emerged as a grassroots social justice movement emphasising empowerment and systemic change, psychiatry remains rooted in the medical paradigm. We aim to develop a nuanced conceptual framework that fosters academic debate and meaningful implementation,
-
Estimating Treatment Effects From Observational Data-Calling It a Target Trial Does Not Make It One. JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-07
Krista F Huybrechts,Sonia Hernández-Díaz -
Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental Disorders JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-07
Alessio Bellato, Joaquim Raduà, Antoine Stocker, Maude-Sophie Lockman, Anusha Lall, Vishnie Ravisankar, Sonia Obiokafor, Emma Machell, Sahar Haq, Dalia Albiaa, Anna Cabras, Douglas Teixeira Leffa, Catarina Manuel, Valeria Parlatini, Assia Riccioni, Christoph U. Correll, Paolo Fusar-Poli, Marco Solmi, Samuele CorteseImportanceRepresentation of race and ethnicity in randomized clinical trials (RCTs) is critical for understanding treatment efficacy across populations with different racial and ethnic backgrounds.ObjectiveTo examine race and ethnicity representation and reporting across RCTs of pharmacotherapies for mental disorders.Data SourcesPubMed (Medline), Embase (Ovid), APA PsycInfo, and Web of Science were
-
Cross-Species Framework for Emotional Well-Being and Brain Aging JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-07
F. Vankee Lin, Janine M. Simmons, Adam Turnbull, Yi Zuo, Yeates Conwell, Kuan Hong WangImportanceEmotional well-being (EWB) is an emerging therapeutic target for managing and preventing symptoms associated with Alzheimer disease and related dementias (ADRD). However, more research is needed to establish causal inferences between brain changes, EWB, and behavioral changes observed in typical aging and ADRD.ObservationsThis article presents a framework for using a cross-species behavioral
-
Antipsychotic Acute-Phase Treatment in Individuals With and Without Recent Treatment JAMA Psychiatry (IF 22.5) Pub Date : 2025-05-07
Lasse Brandt, Orestis Efthimiou, Spyridon Siafis, Johannes Schneider-Thoma, Heiner Stuke, Hakan Ayrilmaz, Alkomiet Hasan, Andreas Heinz, Stefan Gutwinski, John M. Kane, Stefan LeuchtImportanceIt has been hypothesized that the association between acute-phase treatment with antipsychotic (vs placebo) and outcomes might be larger in individuals who were not recently treated compared to recently treated individuals. However, evidence is still lacking.ObjectiveTo compare the association between antipsychotic (vs placebo) acute-phase treatment and outcomes in individuals who were not
-
Internet-Delivered Treatment for Stress-Related Disorders: A Randomized Controlled Superiority Trial of Cognitive Behavioral Therapy versus General Health Promotion. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-05-07
Victoria Sennerstam,Ludwig Franke Föyen,Evelina Kontio,Frank Svärdman,Mats Lekander,Elin Lindsäter,Erik Hedman-LagerlöfBACKGROUND Stress-related disorders such as adjustment disorder (AD) and exhaustion disorder (ED) are associated with substantial suffering and high societal costs. Cognitive behavioral therapy (CBT) is a promising treatment for symptom reduction but has not been rigorously compared with other active treatments. This study aimed to investigate the efficacy of CBT compared to an active control treatment
-
Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-07
Sarah Whittle,Divyangana Rakesh,Julian G Simmons,Orli Schwartz,Nandita Vijayakumar,Nicholas B AllenOBJECTIVE Brain structural alterations are consistently reported in depressive disorders, yet it remains unclear whether these alterations exist prior to disorder onset and thus may reflect a preexisting vulnerability. The authors investigated prospective adolescent neurodevelopmental risk markers for depressive disorder onset, using data from a 15-year longitudinal study. METHODS A community sample
-
Relationship Between Problematic Alcohol Use and Various Psychiatric Disorders: A Genetically Informed Study. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-07
Yeeun Ahn,Jaehyun Kim,Kyeongmin Jung,Dong June Lee,Jin Young Jung,Yewon Eom,Sanghyeon Park,Jaeyoung Kim,Hyejin Kim,Hyeonbin Jo,Sanghoon Hong,Kevin S O'Connell,Ole A Andreassen,Woojae Myung,Hong-Hee WonOBJECTIVE Problematic alcohol use (PAU) adversely affects the clinical course of psychiatric disorders. Genetic studies have suggested that genetic factors underlie the co-occurrence of PAU with psychiatric disorders. This study aimed to elucidate shared genetic architectures, prioritizing genes that disorders may have in common. METHODS Using genome-wide association data of PAU including 435,563 samples
-
Advancing an Inflammatory Subtype of Major Depression. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-07
Andrew H MillerChronic inflammation plays a prominent role in multiple medical disorders, including psychiatric diseases such as major depression. Exposure to inflammatory stimuli leads to changes in neurotransmitter systems and neurocircuits in the brain that are associated with depressive symptoms. Blockade of inflammatory cytokines can reduce depressive symptoms in medically ill and medically healthy individuals
-
Association between genetic liability to physical health conditions and comorbidities in individuals with severe mental illness: an analysis of two cross-sectional observational studies in the UK Lancet Psychiatry (IF 30.8) Pub Date : 2025-05-05
Djenifer B Kappel PhD, Sophie E Smart PhD, Prof Michael J Owen FRCPsych, Prof Michael C O'Donovan FRCPsych, Antonio F Pardiñas PhD, Prof James T R Walters MRCPsychIndividuals with severe mental illness, including schizophrenia and bipolar disorder, have elevated rates of physical health conditions, contributing to increased morbidity and mortality. While environmental factors such as adverse effects from medication and lifestyle changes play a role, the contribution of genetic liability to physical health comorbidities remains underexplored. We investigated
-
Comments on Anne Erreich’s Article “The Innate Capacity for Representing Subjective Experience: The Infant’s Mind Is Neither Primitive nor Prerepresentational” J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-05
Fredric N. Busch -
“That’s What You Say”: Response to Fredric Busch J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2025-05-05
Anne Erreich -
Psychotherapy Trends in the United States. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Mark Olfson,Chandler McClellan,Samuel H Zuvekas,Melanie Wall,Carlos BlancoOBJECTIVE The authors investigated recent national trends in outpatient mental health care and psychotherapy. METHOD Service data from four representative surveys of the U.S. household population, the 2018-2021 Medical Expenditure Panel Survey, were analyzed focusing on adults with outpatient mental health visits (N=17,821) including psychotherapy visits (N=6,415). The authors present trends in age
-
Beyond Either/Or: The Next Chapter in PTSD and Alcohol Use Disorder Treatment Research. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Denise Nguyen Hien,Teresa Lopez-Castro -
Randomized Controlled Trial of "Bounce Back Now," a Mobile App to Reduce Post-Disaster Symptoms of Posttraumatic Stress, Depressed Mood, and Sleep Disturbance. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Kenneth J Ruggiero,Arthur Andrews,Tatiana M Davidson,Yulia Gavrilova,Brian E Bunnell,Jennifer Dahne,Matthew Price,Zoe M F Brier,Gregory Cohen,Dean Kilpatrick,Ron Acierno,Sandro GaleaOBJECTIVE There is tremendous public health interest in cost-efficient, scalable interventions to improve post-disaster mental health. The authors examined the efficacy of Bounce Back Now (BBN), a mobile application, versus an enhanced usual care app (EUC). METHODS A population-based trial was conducted with a diverse sample of 1,357 adults affected by Hurricane Harvey, Irma, Maria, Florence, or Michael
-
Diverse Treatment Strategies and the Valuable Work That Brings Them Forward. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Ned H Kalin -
Problems With Noninferiority Designs in PTSD Treatment Research: Losing Signal to Noise. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Sheila A M Rauch,H Myra Kim,Ron Acierno,Peter W Tuerk,Barbara O Rothbaum